Foreign particles in drug products represent a quality problem for all pharmaceutical manufacturers. They are of a particular concern in the production of pulmonary-inhalable drugs, where the critical size range extends down to 2 microns. By Aspex
Karl Yorgey works with the GPCD in the pre-clinical organization for Johnson & Johnson, supporting all of the GLP applications within preclinical. Thermo Electron Corporation’s LIMS, Watson, is one such application.
Developing staff through innovative learning solutions is key to success. Mike McIntyre of MindCrossings speaks to NGP to give some advice on how to nurture and develop your most precious resource: your people.